• Tchaikapharma obtains a marketing authorisation for Koolsart – a medicinal product for the treatment of arterial hypertension

    January 4, 2016

    Tchaikapharma High Quality Medicines Inc. has obtained a new marketing authorisation for the medicinal product Coolsart – 20 mg/12.5 mg, 20 mg/25 mg, 40 mg/12.5 mg, 40 mg/25 mg film-coated tablets.

    Coolsart contains two active substances: olmesartan medoxomil and hydrochlorothiazide, which are used to treat high blood pressure (hypertension).

    Olmesartan medoxomil belongs to the group of antagonists of angiotensin II. It lowers blood pressure by dilating the blood vessels. Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics („water tablets”). It lowers blood pressure by helping the body excrete excess fluid and stimulating the kidneys to excrete a greater volume of urine.

    Coolsart 20 mg/12.5 mg film-coated tablets is prescribed in case the treatment with olmesartan medoxomil alone does not control blood pressure adequately. When administered together, the two active substances in this medicine helps lower blood pressure to a greater extent than if taken alone.

    ATC code: C09DA08